Sandoz Files Lawsuit Alleging Amgen Illegally Blocked Biosimilar Competition For Its Blockbuster Arthritis Drug - Sandoz Group (OTC:SDZNY), Amgen (NASDAQ:AMGN)

Sandoz Files Lawsuit Alleging Amgen Illegally Blocked Biosimilar Competition For Its Blockbuster Arthritis Drug - Sandoz Group (OTC:SDZNY), Amgen (NASDAQ:AMGN) — alphai